Halozyme Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.

About HALO

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. 

CEO
Helen I. Torley
CEOHelen I. Torley
Employees
350
Employees350
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
350
Employees350

HALO Key Statistics

Market cap
6.65B
Market cap6.65B
Price-Earnings ratio
14.28
Price-Earnings ratio14.28
Dividend yield
Dividend yield
Average volume
4.35M
Average volume4.35M
High today
$54.17
High today$54.17
Low today
$53.33
Low today$53.33
Open price
$53.73
Open price$53.73
Volume
867.43K
Volume867.43K
52 Week high
$70.51
52 Week high$70.51
52 Week low
$42.01
52 Week low$42.01

HALO News

Simply Wall St 13h
High Growth Tech Stocks In The US Market With Promising Potential

The U.S. stock market has recently experienced a surge, with the S&P 500 and Nasdaq Composite reaching new all-time highs following a robust June jobs report th...

High Growth Tech Stocks In The US Market With Promising Potential

Analyst ratings

56%

of 9 ratings
Buy
55.6%
Hold
33.3%
Sell
11.1%

People also own

Based on the portfolios of people who own HALO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.